Literature DB >> 19642912

Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome.

Naresh Ranjith1, Rosemary J Pegoraro, Lee Rom.   

Abstract

BACKGROUND: The objective of this study was to examine the association between serum lipid levels and the metabolic syndrome, together with polymorphisms in lipid-associated genes, in young Asian Indians with acute myocardial infarction (AMI).
METHODS: The study population comprised 492 patients who were 45 years old or younger. We assessed lipid levels and the frequencies of the cholesteryl ester transfer protein (CETP) Taq-1 B, lipoprotein lipase (LPL)S447X, -93 T/G, apolipoprotein B (APO B) 96bp ins/del, lipoprotein(a) (LP[a]) pentanucleotide repeat, and apolipoprotein E (APO) E epsilon 2/3/4 polymorphisms in relation to the metabolic syndrome using both National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and International Diabetes Federation (IDF) definitions.
RESULTS: The metabolic syndrome as defined by the NCEP ATP III criteria was found in 301 (61%) patients and in 295 (60%) patients according to the IDF criteria. Hypercholesterolemia (64.5%), hypertriglyceridaemia (78.7%), low high-density lipoprotein cholesterol (HDL-C) (70.1%), and raised non-HDL-C (68.0%) occurred significantly more frequently in patients with the metabolic syndrome defined by the NCEP ATP III criteria. Similar results were observed for the IDF definition. A significant relationship with the LPL -93 T/G polymorphism was found, with the minor G allele occurring more frequently in patients defined by the NCEP ATP III criteria (odds ratio [OR] 2.72; 95% confidence interval [CI] 1.07-8.16; P = 0.023). The X allele of the LPL S447X polymorphism was observed less frequently in metabolic syndrome patients (OR 0.52; 95% CI 0.34-0.78; P = 0.0009). Several genotypes, including the LPL S447X, APO E3/E3, and the CETP Taq1 B2B2, were associated with favorable lipid profiles.
CONCLUSION: Dyslipidemia occurred with similar frequency in young Asian Indian patients with AMI and the metabolic syndrome, irrespective of the definition used. Significant associations were observed between LPL gene polymorphisms and the metabolic syndrome. Several lipid-associated genotypes exerted a favorable effect on lipid profiles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19642912     DOI: 10.1089/met.2009.0015

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  6 in total

1.  Lack of association of apolipoprotein E (Apo E) polymorphism with the prevalence of metabolic syndrome: the National Heart, Lung and Blood Institute Family Heart Study.

Authors:  Lana Y H Lai; Andrew B Petrone; James S Pankow; Donna K Arnett; Kari E North; R Curtis Ellison; Steven C Hunt; James L Rosenzweig; Luc Djoussé
Journal:  Diabetes Metab Res Rev       Date:  2015-04-06       Impact factor: 4.876

Review 2.  Diabetes and associated complications in the South Asian population.

Authors:  Arti Shah; Alka M Kanaya
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

3.  The Association of a Rare Variant of -93, -53 Promoter Gene Polymorphisms of Lipoprotein Lipase gene with Obesity and Insulin Resistance.

Authors:  Jai Prakash; Balraj Mittal; Apurva Srivastava; Shally Awasthi; Neena Srivastava
Journal:  Oman Med J       Date:  2018-09

4.  Metabolic syndrome in South Asians.

Authors:  Kaushik Pandit; Soumik Goswami; Sujoy Ghosh; Pradip Mukhopadhyay; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2012-01

5.  Genome-wide association study of metabolic syndrome in koreans.

Authors:  Seok Won Jeong; Myungguen Chung; Soo-Jung Park; Seong Beom Cho; Kyung-Won Hong
Journal:  Genomics Inform       Date:  2014-12-31

6.  Association of Metabolic Syndrome with Aerobic Exercise and LPL rs3779788 Polymorphism in Taiwan Biobank Individuals.

Authors:  Chun-Sheng Hsu; Shin-Tsu Chang; Oswald Ndi Nfor; Kuan-Jung Lee; Chien-Chang Ho; Chuan-Ching Liu; Shiuan-Shinn Lee; Yung-Po Liaw
Journal:  Diabetes Metab Syndr Obes       Date:  2021-09-14       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.